Bad medicine: the prescription drug industry in the Third World
Authors: | ; ; |
---|---|
Format: | Print Book |
Language: | English |
Subito Delivery Service: | Order now. |
Check availability: | HBZ Gateway |
WorldCat: | WorldCat |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Stanford, Calif.
Stanford University Press
1992
|
In: | Year: 1992 |
Reviews: | Bad Medicine. The Prescription Drug Industry in the Third World. M. Silverman, M. Lydecker, Ph. R. Lee. Stanford, California: Stanford University Press, 1992, ISBN 0-8047-1669-2 (1993) (Leisinger, Klaus M.)
|
Standardized Subjects / Keyword chains: | B
Developing countries
/ Pharmaceutical supply
/ Health policy
B Developing countries / Pharmaceutical industry / Economic ethics |
Further subjects: | B
Pharmaceutical Industry
Corrupt practices
Developing countries
B Pharmacy law and legislation B Developing countries B Pharmaceutical policy Developing countries B Pharmaindustrie |
Online Access: |
Inhaltsverzeichnis (Verlag) Inhaltsverzeichnis (Verlag) |
MARC
LEADER | 00000cam a2200000 4500 | ||
---|---|---|---|
001 | 278233457 | ||
003 | DE-627 | ||
005 | 20240329015115.0 | ||
007 | tu | ||
008 | 920708s1992 xxu||||| 00| ||eng c | ||
020 | |a 0804716692 |9 0-8047-1669-2 | ||
035 | |a (DE-627)278233457 | ||
035 | |a (DE-576)029015286 | ||
035 | |a (DE-599)GBV278233457 | ||
035 | |a (OCoLC)24376708 | ||
035 | |a (OCoLC)231469833 | ||
035 | |a (OCoLC)24376708 | ||
035 | |a (DE-604)8066282977 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
044 | |c XD-US | ||
050 | 0 | |a HD9674.D44 | |
060 | 0 | |a QV 736 S587b | |
082 | 0 | |a 338.476151091724 | |
082 | 0 | |a 338.4/76151/091724 | |
084 | |a 1 |2 ssgn | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Silverman, Milton |4 aut | |
245 | 1 | 0 | |a Bad medicine |b the prescription drug industry in the Third World |c Milton Silverman; Philip R. Lee; Philip R. Lee |
264 | 1 | |a Stanford, Calif. |b Stanford University Press |c 1992 | |
300 | |a XVII, 358 S. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references (p. [319]-339) and index | ||
583 | 1 | |a Archivierung prüfen |c 20200919 |f DE-640 |z 2 |2 pdager | |
583 | 1 | |a Archivierung prüfen |c 20240324 |f DE-4165 |z 1 |2 pdager | |
601 | |a Industrie | ||
650 | 7 | |8 1.1\x |a Pharmaindustrie |0 (DE-627)091383137 |0 (DE-2867)13002-3 |2 stw | |
650 | 7 | |8 1.2\x |a Entwicklungsländer |0 (DE-627)09135742X |0 (DE-2867)10492-3 |2 stw | |
650 | 7 | |8 1.3\x |a Arzneimittelrecht |0 (DE-627)091348099 |0 (DE-2867)18259-4 |2 stw | |
650 | 0 | |a Pharmaceutical Industry |x Corrupt practices |x Developing countries | |
650 | 0 | |a Pharmaceutical policy |x Developing countries | |
689 | 0 | 0 | |d g |0 (DE-588)4014954-7 |0 (DE-627)104493925 |0 (DE-576)208909974 |2 gnd |a Entwicklungsländer |
689 | 0 | 1 | |d s |0 (DE-588)4140783-0 |0 (DE-627)104279257 |0 (DE-576)209705744 |2 gnd |a Arzneimittelversorgung |
689 | 0 | 2 | |d s |0 (DE-588)4113743-7 |0 (DE-627)105827177 |0 (DE-576)209478977 |2 gnd |a Gesundheitspolitik |
689 | 0 | |5 (DE-627) | |
689 | 1 | 0 | |d g |0 (DE-588)4014954-7 |0 (DE-627)104493925 |0 (DE-576)208909974 |2 gnd |a Entwicklungsländer |
689 | 1 | 1 | |d s |0 (DE-588)4045696-1 |0 (DE-627)106200690 |0 (DE-576)209066393 |2 gnd |a Pharmazeutische Industrie |
689 | 1 | 2 | |d s |0 (DE-588)4066439-9 |0 (DE-627)104137525 |0 (DE-576)209164603 |2 gnd |a Wirtschaftsethik |
689 | 1 | |5 (DE-627) | |
700 | 1 | |a Lee, Philip R. |4 aut | |
700 | 1 | |a Lydecker, Mia |4 aut | |
787 | 0 | 8 | |i Rezensiert in |a Leisinger, Klaus M. |t Bad Medicine. The Prescription Drug Industry in the Third World. M. Silverman, M. Lydecker, Ph. R. Lee. Stanford, California: Stanford University Press, 1992, ISBN 0-8047-1669-2 |d 1993 |w (DE-627)1827973358 |
856 | 4 | 2 | |u http://www.gbv.de/dms/hbz/toc/ht004447714.PDF |m V:DE-605 |v 2008-11-15 |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
856 | 4 | 2 | |u http://www.gbv.de/dms/bs/toc/025054546.pdf |m V:DE-601 |m B:DE-84 |q pdf/application |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
889 | |w (DE-627)025054546 | ||
889 | |w (DE-627)256795312 | ||
935 | |i mdedup | ||
935 | |i Blocktest | ||
936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |0 (DE-627)106423304 |
951 | |a BO | ||
ELC | |b 1 | ||
ORI | |a SA-MARC-ixtheo_oa001.raw | ||
REL | |a 1 | ||
STA | 0 | 0 | |a Developing countries,Developing countries,Third world,Economic ethics,Economic ethics,Health policy,Pharmaceutical industry,Pharmaceutical supply,Pharmacy law and legislation |
STB | 0 | 0 | |a Approvisionnement en médicaments,Droit pharmaceutique,Industrie pharmaceutique,Pays en voie de développement,Politique sanitaire,Éthique économique,Éthique économique |
STC | 0 | 0 | |a Abastecimiento con medicamentos,Industria farmacéutica,Legislación farmacéutica,Países en desarrollo,Política de salud,Ética económica,Ética económica |
STD | 0 | 0 | |a Approvvigionamento di farmaci,Diritto farmaceutico,Etica economica,Etica economica,Industria farmaceutica,Paesi in via di sviluppo,Politiche sanitarie |
STE | 0 | 0 | |a 卫生政策,健康政策,医疗政策,经济伦理,经济伦理 |
STF | 0 | 0 | |a 制药产业,經濟倫理,經濟倫理,衛生政策,健康政策,醫療政策 |
STG | 0 | 0 | |a Abastecimento com medicamentos,Indústria farmacêutica,Legislação farmacêutica,Países em desenvolvimento,Política de saúde,Ética econômica,Ética econômica |
STH | 0 | 0 | |a Обеспечение лекарственными препаратами,Политика здравоохранения,Право на изготовление лекарственных препаратов,Развивающиеся страны (мотив),Фармацевтическая промышленность,Экономическая этика (мотив),Экономическая этика |
STI | 0 | 0 | |a Αναπτυσσόμενες χώρες (μοτίβο),Οικονομική ηθική (μοτίβο),Οικονομική ηθική,Πολιτική υγείας,Προμήθεια φαρμάκων,Φαρμακευτική νομοθεσία,Φαρμακευτικό δίκαιο,Φαρμακοβιομηχανία,Φαρμακευτική βιομηχανία |
SUB | |a REL | ||
SYE | 0 | 0 | |a Developing countries,Arme Länder,Dritte Welt,LDC (Less Developed Countries),Less developed countries,Low-income countries,Niedrigeinkommensländer,Underdeveloped countries,Unterentwickelte Länder , Dritte Welt,Unterentwickelte Länder,Entwicklungsland,Less developed Countries,LDC,Global South,Globaler Süden , Arzneimittel |
SYG | 0 | 0 | |a Developing countries,Arme Länder,Dritte Welt,LDC (Less Developed Countries),Less developed countries,Low-income countries,Niedrigeinkommensländer,Underdeveloped countries,Unterentwickelte Länder , Dritte Welt,Unterentwickelte Länder,Entwicklungsland,Less developed Countries,LDC,Global South,Globaler Süden , Arzneimittel,Medikamentenversorgung,Medikament , Gesundheit , Developing countries,Arme Länder,Dritte Welt,LDC (Less Developed Countries),Less developed countries,Low-income countries,Niedrigeinkommensländer,Underdeveloped countries,Unterentwickelte Länder , Dritte Welt,Unterentwickelte Länder,Entwicklungsland,Less developed Countries,LDC,Global South,Globaler Süden , Arzneimittelindustrie,Pharmaindustrie,Pharmazieindustrie,Arzneimittel,Pharmakonzern , Wirtschaft - Wirtschaftsethik,Economic ethics,Wirtschaftsmoral,Wirtschaft |